Lanreotide Impurity 2 is a structurally related analogue arising during lanreotide synthesis or degradation pathways. Differences in side-chain composition or linking pattern subtly alter conformation and chromatographic behavior. Researchers characterize it to understand process-related modifications and stability. Applications include analytical-method qualification, impurity tracking, and peptide-structure comparison studies.
CAT No: Z10-101-194
CAS No:109605-17-6
Synonyms/Alias:(4R,7S,10S,13R,16S,19S)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-acetamido-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More